Park Ha Biological Technology Co., Ltd. · NASDAQ:BYAH
Park Ha Biological Technology — IPO Roadshow (December 2024)
20 slides from Park Ha Biological Technology's IPO roadshow presentation, Dec 3, 2024
Slide 1: Investor Presentation December 2024
Proposed Nasdaq Ticker: PHH Investor Presentation December 2024 Issuer Free Writing Prospectus dated December 4 , 2024 Filed Pursuant to Rule 433 of the Securities Act of 1933, as amended Relating to Preliminary Prospectus dated October 9, 2024 Registration Statement No. 333 - 281783
Slide 2: Free Writing Prospectus Disclaimer
Free Writing Prospectus Disclaimer This free writing prospectus relates to the proposed public offering of ordinary shares (“Ordinary Shares”) of Park Ha Biological Technology Co . , Ltd . (“we”, “us”, or “our”) and highlights basic information about us and the offering . Because it is a summary, it
Slide 3: Forward-Looking Statements
Forward - Looking Statements This presentation contains forward - looking statements . All statements contained in this prospectus other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and ou
Slide 4: Offering Summary
Offering Summary Park Ha Biological Technology Co., Ltd. Issuer Ordinary Shares Securities Initial Public Offering Offering Type Nasdaq Capital Market: PHH Proposed Listing/Symbol 1,200,000 Ordinary Shares, excluding exercise of the over - allotment option, 1,380,000 Ordinary Shares, assuming full e
Slide 5: Company Overview
Company Overview Provide cost - effective solutions to skin problems and improve the confidence of women in need of skin treatment We focus on developing private skincare label, direct skincare products sales and franchise alliances promotions. Our Highlights 2016 Established Nearly 200 P roducts 8
Slide 6: Corporate Structure
Corporate Structure Public Shareholders Other Existing Shareholders Changxin International Limited Partnership BVI Xiaoqiu Holding Ltd BVI Park Ha Biological Technology Co., Ltd. (“Park Ha Cayman”) Cayman Islands Park Ha Biological Technology (HK) Co., Ltd. (“Park Ha HK”) Hong Kong Park Ha Investmen
Slide 7: Key Milestones
Key Milestones 2016 2017 2019 2020 2022 Xinzhan incorporated Park Ha Shanghai incorporated First store launched Park Ha Jiangsu incorporated “Park Ha” brand started to establish official accounts on short - formed video platforms in China Park Ha Biological Technology Co., Ltd., incorporated 7 See o
Slide 8: Business Overview
Business Overview Note: *As of April 30, 2024 Located in 1/2/3 - tier cities in 14 provinces & 1 municipality in China Park Ha Providing skincare and cosmetic products Geni or 歌妮 Sell products from the “Park Ha” brand and other third - party brands with our permission 119.94 m² 11 employees 43 Franc
Slide 9: Company Products
Company Products “Park Ha” skincare products • Basic skin physical protection • Exfoliation 200 products across 18 series, covers almost all common categories in the skincare industry • Collaborate with biological laboratories and supply chain systems • Expand reach via franchise partnerships • Sebu
Slide 10: Value-added Service
Value - added Service Complimentary After - Sales Beauty Services • Offered in directly - operated stores and franchisees stores • Aimed at demonstrating effective product usage for best results • 30 - 45 minute complimentary sessions • Effective way to demonstrate how our products are used in order
Slide 11: Sales & Marketing
Sales & Marketing Online to reach a wider audience, attract and engage new customers • E - commerce Strategies • Digital Coupons • Group - buying Deals Offline to build a closer relationship with customers to enhance experience with our products • A Prominent Product Trial Area • Trained Aestheticia
Slide 12: Competitive Advantages
Competitive Advantages Innovative Social Marketing Model • Established regional brand effect through local salon activities and internet promotions • Organize virtual events via WeChat, connecting people interested in skincare • Target potential customers through interest - based community activitie
Slide 13: Management Team
Management Team Xiaoqiu Zhang Chief Executive Officer Chairperson of the Board of Directors Ms . Zhang became CEO of Park Ha Cayman on July 5 , 2023 . Ms . Zhang has served as the CEO of Xinzhan since March 2016 . Ms . Zhang has over 10 years of business success, with a diverse knowledge of op
Slide 14: Board of Directors
Board of Directors Chief Executive Officer Chairperson of the Board of Directors Xiaoqiu Zhang Ms . Zhang became CEO of Park Ha Cayman on July 5 , 2023 . Ms . Zhang has served as the CEO of Xinzhan since March 2016 . Ms . Zhang has over 10 years of business success, with a diverse knowledge of
Slide 15: Growth Strategies
Growth Strategies Strengthening the Development of O wn Products E xpand our partnership with scientific research institutions to develop new skincare raw materials and products, and expand th e s cope of services to existing customers and acquire new customers by continually making significant inve
Slide 16: Financial Highlights: Revenue Breakdown FY2022-FY2023
17% 34% 49% Financial Highlights Revenue Breakdown FY2022 Audited FY2023 Audited Products sales – Non - franchisees Product sales – Franchisees Franchise fees 1.92 2.46 FY2022 Audited FY2023 Audited Revenue US$ Million Fiscal years ended October 31, 2023 vs. 2022 12% 14% 74% See offering documents f
Slide 17: Financial Highlights: Revenue Breakdown 1H 2023 vs 1H 2024
Financial Highlights Revenue Breakdown 1.37 0.85 1H 2023 Unaudited 1H 2024 Unaudited Revenue US$ Million 1H 2023 Unaudited 1H 2024 Unaudited Products sales – Non - franchisees Product sales – Franchisees Franchise fees Reasons for revenue decreases from 1H2023 to 1H2024 are primarily attributable to
Slide 18: Financial Highlights: Gross Profit and Net Income FY2022-FY2023
1.41 2.15 FY2022 Audited FY2023 Audited Financial Highlights US$ Million Gross Profit and Gross Profit Margin US$ Million 0.19 0.85 FY2022 Audited FY2023 Audited Net Income 87% 73% See offering documents for risks and disclosures. There is no guarantee that any specific outcome will be achieved. Inv
Slide 19: Financial Highlights: Gross Profit and Net Income 1H 2023 vs 1H 2024
1.25 0.75 1H 2023 Unaudited 1H 2024 Unaudited Financial Highlights US$ Million Gross Profit and Gross Profit Margin US$ Million 0.50 0.05 1H 2023 Unaudited 1H 2024 Unaudited Net Income 91% 88% 19 See offering documents for risks and disclosures. There is no guarantee that any specific outcome will b
Slide 20: Contact
Contact Underwriter: Dawson James Securities, Inc . Email: investmentbanking@dawsonjames.com Tel : +1 (561) 391 - 5555 Address : 101 N. Federal Highway Suite 600 Boca Raton, Florida 33432 Underwriter: D. Boral Capital LLC Email : info@dboralcapital.com Tel : +1 (212) 970 - 5150 Address: 590 Madison
Park Ha Biological Technology — IPO Roadshow (December 2024) on 6ix